EP0500826A4 - Apo ai polypeptides, antibodies, and immunoassays - Google Patents

Apo ai polypeptides, antibodies, and immunoassays

Info

Publication number
EP0500826A4
EP0500826A4 EP19910912441 EP91912441A EP0500826A4 EP 0500826 A4 EP0500826 A4 EP 0500826A4 EP 19910912441 EP19910912441 EP 19910912441 EP 91912441 A EP91912441 A EP 91912441A EP 0500826 A4 EP0500826 A4 EP 0500826A4
Authority
EP
European Patent Office
Prior art keywords
apo
immunoassays
polypeptides
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP19910912441
Other versions
EP0500826A1 (en
Inventor
Linda K. Curtiss
Carole L. Banka
David J. Bonnet
Richard S. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of EP0500826A1 publication Critical patent/EP0500826A1/en
Publication of EP0500826A4 publication Critical patent/EP0500826A4/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP19910912441 1990-06-07 1991-06-07 Apo ai polypeptides, antibodies, and immunoassays Ceased EP0500826A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53476190A 1990-06-07 1990-06-07
US534761 1995-09-27

Publications (2)

Publication Number Publication Date
EP0500826A1 EP0500826A1 (en) 1992-09-02
EP0500826A4 true EP0500826A4 (en) 1993-06-30

Family

ID=24131429

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910912441 Ceased EP0500826A4 (en) 1990-06-07 1991-06-07 Apo ai polypeptides, antibodies, and immunoassays

Country Status (6)

Country Link
EP (1) EP0500826A4 (en)
JP (1) JPH06508344A (en)
CA (1) CA2084677C (en)
IE (1) IE911922A1 (en)
PT (1) PT97914B (en)
WO (1) WO1991018619A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125678B2 (en) 2001-11-23 2006-10-24 Nanogen, Inc. Protein biopolymer markers predictive of type II diabetes
CA2958672A1 (en) 2007-06-15 2008-12-18 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Treatment of tumors using specific anti-l1 antibody
NO335243B1 (en) 2008-01-08 2014-10-27 Isola As Cradle plate, as well as the application and method of laying a floor covering using such a cradle plate.
WO2018181935A1 (en) * 2017-03-30 2018-10-04 シスメックス株式会社 Anti-apoa1 antibody

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004486A1 (en) * 1987-11-03 1989-05-18 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
WO1989009403A1 (en) * 1988-03-29 1989-10-05 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004486A1 (en) * 1987-11-03 1989-05-18 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
WO1989009403A1 (en) * 1988-03-29 1989-10-05 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9118619A1 *

Also Published As

Publication number Publication date
PT97914B (en) 1998-11-30
JPH06508344A (en) 1994-09-22
WO1991018619A1 (en) 1991-12-12
PT97914A (en) 1992-03-31
EP0500826A1 (en) 1992-09-02
CA2084677A1 (en) 1991-12-08
CA2084677C (en) 2003-11-04
IE911922A1 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
EP0362332A4 (en) Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
AU1183295A (en) Immunoassays employing generic anti-hapten antibodies and materials for use therein
IL109159A (en) Immunoassays for tetrachloroiso-phthalonitrile and its metabolites and antibodies for use therein
GB9009549D0 (en) Recombinant antibody and method
EP0634019A4 (en) Immunoassays employing generic anti-hapten antibodies and materials for use therein.
EP0451848A3 (en) Immunoassay element and process for immunoassay
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
IL100841A0 (en) Immunoassay
IL90017A0 (en) Monoclonal antibodies
ZA898777B (en) Monoclonal antibodies
IL92232A0 (en) Anti-fucosylceramide monoclonal antibody
IL92861A0 (en) Homogeneous immunoassay
EP0500826A4 (en) Apo ai polypeptides, antibodies, and immunoassays
ZA89258B (en) Monoclonal antibodies
EP0381763A4 (en) Antibody modified with toxin
GB8820036D0 (en) Monoclonal antibodies
GB9223676D0 (en) Modified antibodies
GB9014652D0 (en) Antigen
EP0423333A4 (en) Anti-endoserine antibody
GB8812137D0 (en) Antibodies
EP0336441A3 (en) Anti-cpbii monoclonal antibody
ZA912136B (en) Anti-oncostatin m monoclonal antibodies
GB9115010D0 (en) Antibody
AU9161991A (en) Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
GB9003784D0 (en) Glycoprotein immunoassay

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920508

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

RHK1 Main classification (correction)

Ipc: C07K 15/16

A4 Supplementary search report drawn up and despatched

Effective date: 19930511

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19951109

RHK1 Main classification (correction)

Ipc: C07K 7/04

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RHK1 Main classification (correction)

Ipc: C07K 7/04

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19970707